Get the Stockscreener App
0.71
2.01%
0.014
Pre-market:
.72
0.01
+1.41%
Cdt Equity Inc stock is traded at $0.71, with a volume of 83,230.
It is up +2.01% in the last 24 hours and down -58.84% over the past month.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
See More
Previous Close:
$0.696
Open:
$0.757
24h Volume:
83,230
Relative Volume:
0.09
Market Cap:
$3.45M
Revenue:
-
Net Income/Loss:
$-39.62M
P/E Ratio:
-0.000429
EPS:
-1654.3275
Net Cash Flow:
$-17.96M
1W Performance:
-8.39%
1M Performance:
-58.84%
6M Performance:
-98.39%
1Y Performance:
-99.85%
1-Day Range:
$0.70
$0.757
1-Week Range:
$0.6705
$0.7945
52-Week Range:
$0.6705
$610.00
Cdt Equity Inc Stock (CDT) Company Profile
Name
Cdt Equity Inc
Sector
Industry
Phone
(646) 491 9132
Address
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
0.71 | 3.45M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
450.46 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.98 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.20 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.80 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
160.06 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cdt Equity Inc Stock (CDT) Latest News
CDTG (CDTG) director Cui Lijun files initial Form 3 with no transactions - Stock Titan
CDT Equity Inc. (CDT) Faces Pressure: Stock Drops 3% to $0.70 Amidst Support TestMax Pain Level - newsline.com
Number of shareholders of CDT Equity Inc. – NASDAQ:CDTTW - TradingView
The Psychology and Financial Implications of Splitting the Dinner Bill EquallyReturn On Equity - newsline.com
CDT News | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
Chinese Startup Dilemma Exposes Structural Risks in Beijing’s Direct Tech Equity ModelEBITDA Estimate Trend - newsline.com
CDT Equity Inc. (CDT) Gains 1.9% as Stock Bounces from Key SupportBollinger Squeeze - newsline.com
CDT Equity receives Nasdaq notice over delayed quarterly filing - MSN
CDT and Liam Moor Acquire Atlantic at Twin Hickory to Preserve Affordable Senior Homes in Glen Allen, Va - Weekly Voice
M&S Launches Youth Traineeship Program for 1,000 Young People to Tackle NEET ChallengeEarnings Beat Alert - newsline.com
[SCHEDULE 13G] CDT Equity Inc. Passive Investment Disclosure (>5%) - Stock Titan
CDT Equity Surges As AZD5904 Patent Wins Drive Speculation - timothysykes.com
CDT Equity Inc. (CDT) Surges 9.5%: Examining the Move Above $1.00Force Index - newsline.com
CDT Equity Company Profile & Introduction - Moomoo
CDT Equity AZD5904 Patents Power Bullish Trading Setup - timothysykes.com
Crane Harbor Acquisition Corp. II Rights (CRANR) Holds Near Support at $0.20 Amid Minimal MovementFibonacci Arc - The Legal Advocate
CDT Equity Jumps As AZD5904 Patent Wins Fuel Deal Hopes - StocksToTrade
CDT Equity Jumps As AZD5904 Patent Wins Fuel Licensing Hopes - StocksToTrade
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
CDT Faces Nasdaq Compliance Notice Due to Filing Delay - GuruFocus
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter - Moomoo
Friday's session: gap up and gap down stocks - ChartMill
CDT Equity Receives Nasdaq Notice Over Late Filing - TipRanks
CDT Equity Inc. Receives Nasdaq Deficiency Letter for Non-Compliance - geneonline.com
CDT Equityhas until July 20, 2026 to submit Nasdaq compliance plan - marketscreener.com
Nasdaq warns CDT Equity (CDT) over delayed Form 10-Q but trading continues - Stock Titan
CDTTW Warrants Remain at Floor Level – CDT Equity Inc. (CDTTW) Shows No Price MovementArms Index - The Legal Advocate
CDT Environmental Technology Investment Holdings Limited Announces Share Consolidation - Yahoo Finance
CDTTW Warrants Trade Flat at $0.01 Amidst Minimal ActivityOverbought Signal Alerts - The Legal Advocate
CDT Equity Inc. Warrant (CDTTW) Holds at $0.01 – A Penny Stock at a Trading CrossroadsGap and Go - The Legal Advocate
CDT Equity receives Canadian patent for male infertility drug By Investing.com - Investing.com Nigeria
CDT Equity receives Canadian patent for male infertility drug - Investing.com
No approved drugs for male infertility — but CDT just secured a key patent - Stock Titan
AZN's Patent Granted in Canada Strengthens Position in Male Infe - GuruFocus
CDTTW Warrants Remain Static at $0.01 – Analysis of Current StalemateShort Term Trading Ideas - The Legal Advocate
CDT Equity Inc. Warrant (CDTTW) Holds at $0.01 – Minimal Movement Amid Thin TradingDelta Hedging - The Legal Advocate
CDT Equity Inc. (CDT) Falls Sharply: Key Support Levels in Focus After 13.9% DeclineMomentum Stock Picks - The Legal Advocate
CDT Equity Inc. (CDT) Plunges 14% as Selling Pressure Intensifies Below $1.10 ResistanceNaked POC - Newser
Nirland-controlled group reports 75,315 CDT shares (NASDAQ: CDT) - Stock Titan
Equity Inc (CDT) Stock Analysis: Climbs +3.33%, Eyes on $1.30 2026-05-20Social Trading Insights - Newser
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split - Yahoo Finance
TSF Investments Reports 28% Jump in Consolidated Net Profit, Boosted by Equity Revaluation GainMid-Term Outlook - newsline.com
12 Health Care Stocks Moving In Monday's After-Market SessionAIM ImmunoTech (AMEX:AIM), Atlantic Inter - Benzinga
CDT Equity Flags Delay in Quarterly Filing - TipRanks
CDT Equity Modifies Financing Agreements to Boost Liquidity - TipRanks
CDT Equity (NASDAQ: CDT) notifies SEC of delayed Q1 2026 10-Q; plans filing - Stock Titan
Cdt Equity Inc enters amendment no. 2 to equity line of credit facility on May 15, 2026SEC filing - marketscreener.com
CDT Equity Inc. (NASDAQ: CDT) tweaks equity line and note proceeds - Stock Titan
Cdt Equity Inc Stock (CDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):